Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-22 4:39 pm Purchase |
2023-11-13 | 13D | Cartesian Therapeutics, Inc. RNAC |
Singer Michael | 868,698 13.900% |
868,698 (New Position) |
Filing History |
| 2023-11-22 4:38 pm Purchase |
2023-11-13 | 13D | Cartesian Therapeutics, Inc. RNAC |
Kalayoglu Murat | 1,311,482 19.900% |
1,311,482 (New Position) |
Filing History |
| 2023-11-17 08:15 am Purchase |
2023-11-13 | 13D | Cartesian Therapeutics, Inc. RNAC |
SPRINGER TIMOTHY A | 6,431,355 27.700% |
4,952,803 (+334.98%) |
Filing History |
| 2023-09-22 7:31 pm Purchase |
2022-04-11 | 13D | Cartesian Therapeutics, Inc. RNAC |
SPRINGER TIMOTHY A | 1,478,553 28.900% |
389,789 (+35.80%) |
Filing History |
| 2023-06-12 4:30 pm Purchase |
2023-06-01 | 13G | Cartesian Therapeutics, Inc. RNAC |
Artal Participations S.a r.l | 340,233 6.600% |
340,233 (New Position) |
Filing History |
| 2023-02-14 1:45 pm Purchase |
2022-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
Mangrove Partners IM, LLC | 312,923 5.970% |
33,726 (+12.08%) |
Filing History |
| 2022-07-27 4:37 pm Purchase |
2022-05-13 | 13G | Cartesian Therapeutics, Inc. RNAC |
Mangrove Partners IM, LLC | 279,197 5.370% |
12,500 (+4.69%) |
Filing History |
| 2022-05-23 5:39 pm Purchase |
2022-05-13 | 13G | Cartesian Therapeutics, Inc. RNAC |
Mangrove Partners IM, LLC | 266,697 5.140% |
3,971 (+1.51%) |
Filing History |
| 2022-05-09 3:23 pm Sale |
2022-04-30 | 13G | Cartesian Therapeutics, Inc. RNAC |
BlackRock Inc. BLK |
226,876 4.500% |
-4,853 (-2.09%) |
Filing History |
| 2022-02-14 1:18 pm Sale |
2021-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
BIOTECHNOLOGY VALUE FUND L P | 57,438 1.500% |
-106,766 (-65.02%) |
Filing History |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
BlackRock Inc. BLK |
231,729 6.000% |
49,252 (+26.99%) |
Filing History |
| 2021-12-27 4:05 pm Purchase |
2021-12-15 | 13D | Cartesian Therapeutics, Inc. RNAC |
SPRINGER TIMOTHY A | 1,088,764 28.000% |
7,040 (+0.65%) |
Filing History |
| 2021-12-15 5:14 pm Purchase |
2021-12-09 | 13D | Cartesian Therapeutics, Inc. RNAC |
SPRINGER TIMOTHY A | 1,081,724 27.800% |
127,376 (+13.35%) |
Filing History |
| 2021-05-27 4:11 pm Purchase |
2021-05-21 | 13D | Cartesian Therapeutics, Inc. RNAC |
SPRINGER TIMOTHY A | 954,348 25.300% |
156,449 (+19.61%) |
Filing History |
| 2021-02-16 12:03 pm Purchase |
2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
Mangrove Partners Master Fund Ltd. | 111,097 3.000% |
111,097 (New Position) |
Filing History |
| 2021-02-12 5:19 pm Sale |
2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
EcoR1 Capital LLC | 76,628 2.100% |
-153,257 (-66.67%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
BlackRock Inc. BLK |
182,477 5.100% |
182,477 (New Position) |
Filing History |
| 2020-10-23 5:19 pm Purchase |
2020-10-20 | 13D | Cartesian Therapeutics, Inc. RNAC |
SPRINGER TIMOTHY A | 797,899 22.300% |
184,413 (+30.06%) |
Filing History |
| 2020-10-15 10:10 am Purchase |
2020-10-06 | 13D | Cartesian Therapeutics, Inc. RNAC |
SPRINGER TIMOTHY A | 613,486 17.200% |
115,737 (+23.25%) |
Filing History |
| 2020-08-10 08:40 am Purchase |
2020-07-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
Swedish Orphan Biovitrum AB (publ) | 180,546 6.200% |
180,546 (New Position) |
Filing History |